UCSF

Voigt pioneers field of synthetic biology

Christopher A. Voigt, PhD, UCSF School of Pharmacy scientist, and colleagues are engineering bacteria to target tumors and create images. This work is part of the emerging field of synthetic biology, which aims to create new biological parts, systems, and tools, and redesign existing biological systems for useful purposes, including:

  • new treatments for disease
  • new manufacturing processes
  • green materials
  • new ways to clean up the environment.

Full story: [Synthetic Biology Yields Bacteria That Take Pictures and Target Tumors][link defunct as of April 1, 2013] Christopher A. Voigt, PhD, UCSF School of Pharmacy scientist, and colleagues are engineering bacteria to target tumors and create images. This work is part of the emerging field of synthetic biology, which aims to create new biological parts, systems, and tools, and redesign existing biological systems for useful purposes, including:

  • new treatments for disease
  • new manufacturing processes
  • green materials
  • new ways to clean up the environment.

Full story: [Synthetic Biology Yields Bacteria That Take Pictures and Target Tumors][link defunct as of April 1, 2013]

Tags

Category:
Sites:
School of Pharmacy, Department of Pharmaceutical Chemistry, PharmD Degree Program, QBC, CCB, Biophysics

About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.